Om Megashree Pharmaceuticals Incurs Loss

Feb 13, 2026 11:09 AM Merolagani



Om Megashree Pharmaceuticals (OMPL) has published second quarter report of the current FY.

As per the report, it incurred net loss of Rs 38.4 million. In the review period, the company earned operating income of Rs 104.8 million and total income of Rs 105.1 million. Meanwhile, it incurred total expenses of Rs 143.5 million.

The company maintained LPS of Rs 12.81 and net worth per share of Rs 97.93.

The company with paid-up capital of Rs 600 million has retained loss of Rs 74.8 million and other reserve of Rs 62.3 million.




Gold Price Gains, Silver Declines

Feb 15, 2026 10:30 AM

The gold price has gained while the silver price has declined on February 15.

Gold and Silver Price Decline

Feb 18, 2026 10:45 AM

Gold and Silver Price Decline

Feb 16, 2026 10:52 AM

Hotel Forest Inn Allots IPO

Feb 16, 2026 10:20 AM